Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Other financing activities (2017 - 2018)

Cogent Biosciences (COGT) has 1 years of Other financing activities data on record, last reported at $1.5 million in Q2 2018.

  • For Q2 2018, Other financing activities changed N/A year-over-year to $1.5 million; the TTM value through Dec 2018 reached $2.1 million, changed N/A, while the annual FY2025 figure was $48.9 million, N/A changed from the prior year.
  • Other financing activities reached $1.5 million in Q2 2018 per COGT's latest filing, up from $563000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $1.5 million in Q2 2018 and bottomed at $563000.0 in Q1 2018.